Immunohistochemical Diagnostic and Prognostic Markers for Melanoma
Recent studies in our laboratory have identified novel molecular diagnostic and prognostic markers based on analyses in large cohorts of melanoma patients. These markers were initially derived from gene expression profiling analyses of distinct stages of melanoma progression. Immunohistochemical analyses confirmed the differential expression of these markers, and immunohistochemistry-based multimarker assays were developed to assess melanoma diagnosis and prognosis at the molecular level. In this chapter we review the development of these assays and the methodologies used to assess marker expression in both nevi and primary melanomas.
- Impact of Breast Cancer Resistance Protein on Cancer Treatment Outcomes
- Sensitive Detection of Hypermethylated p16INK4a Alleles in Exfoliative Tissue Material
- Immunophenotyping of Plasma Cells in Multiple Myeloma
- Biochemical Analysis of the Native TRAIL Death-Inducing Signaling Complex
- Fluorescence In Situ Hybridization and Comparative Genomic Hybridization
- Cell Aggregation Assays
- Transgenic Mouse Models for Prostate Cancer: Identification of an Androgen-Dependent Promoter and Creation and Characterization
- Xenografting Human Colon Cancers
- 骨髓造血干细胞归巢
- Flow Cytometric Analysis of p53-Induced Apoptosis